Search research articles
Contact Us
Filters
Showing results (91-100 of 119) with videos related to
Page
of 12
Sort By:
AJR. American Journal of Roentgenology
|
August 7, 2020
Prospective Evaluation of <sup>18</sup>F-DCFPyL PET/CT in Detection of High-Risk Localized Prostate Cancer: Comparison With mpMRI
Sonia Gaur, Esther Mena, Stephanie A Harmon, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 16, 2019
<sup>18</sup>F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab
Ilhan Lim, Maria Liza Lindenberg, Esther Mena, et al.
Journal of Imaging Informatics in Medicine
|
April 8, 2024
An Automated Deep Learning-Based Framework for Uptake Segmentation and Classification on PSMA PET/CT Imaging of Patients with Prostate Cancer
Yang Li, Maliha R Imami, Linmei Zhao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 25, 2012
Immuno-PET of the hepatocyte growth factor receptor Met using the 1-armed antibody onartuzumab
Elaine M Jagoda, Lixin Lang, Veerendra Bhadrasetty, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 24, 2015
Comparison of Prostate-Specific Membrane Antigen-Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate Cancer
Steven P Rowe, Katarzyna J Macura, Anthony Ciarallo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 21, 2012
11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation
Esther Mena, Baris Turkbey, Haresh Mani, et al.
Oncotarget
|
February 1, 2019
A comparison of prostate cancer bone metastases on <sup>18</sup>F-Sodium Fluoride and Prostate Specific Membrane Antigen (<sup>18</sup>F-PSMA) PET/CT: Discordant uptake in the same lesion
Stephanie A Harmon, Esther Mena, Joanna H Shih, et al.
European Urology Oncology
|
October 20, 2023
Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide
Shruti U Gandhy, Fatima H Karzai, Marijo Bilusic, et al.
Plos One
|
November 11, 2022
Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinoma
Esther Mena, Joanna Shih, Joon-Yong Chung, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 2018
A Prospective Comparison of <sup>18</sup>F-Sodium Fluoride PET/CT and PSMA-Targeted <sup>18</sup>F-DCFBC PET/CT in Metastatic Prostate Cancer
Stephanie A Harmon, Ethan Bergvall, Esther Mena, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 119) with videos related to
Sort By:
Page
of 12
AJR. American Journal of Roentgenology
|
August 7, 2020
Prospective Evaluation of <sup>18</sup>F-DCFPyL PET/CT in Detection of High-Risk Localized Prostate Cancer: Comparison With mpMRI
Sonia Gaur, Esther Mena, Stephanie A Harmon, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 16, 2019
<sup>18</sup>F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab
Ilhan Lim, Maria Liza Lindenberg, Esther Mena, et al.
Journal of Imaging Informatics in Medicine
|
April 8, 2024
An Automated Deep Learning-Based Framework for Uptake Segmentation and Classification on PSMA PET/CT Imaging of Patients with Prostate Cancer
Yang Li, Maliha R Imami, Linmei Zhao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 25, 2012
Immuno-PET of the hepatocyte growth factor receptor Met using the 1-armed antibody onartuzumab
Elaine M Jagoda, Lixin Lang, Veerendra Bhadrasetty, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 24, 2015
Comparison of Prostate-Specific Membrane Antigen-Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate Cancer
Steven P Rowe, Katarzyna J Macura, Anthony Ciarallo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 21, 2012
11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation
Esther Mena, Baris Turkbey, Haresh Mani, et al.
Oncotarget
|
February 1, 2019
A comparison of prostate cancer bone metastases on <sup>18</sup>F-Sodium Fluoride and Prostate Specific Membrane Antigen (<sup>18</sup>F-PSMA) PET/CT: Discordant uptake in the same lesion
Stephanie A Harmon, Esther Mena, Joanna H Shih, et al.
European Urology Oncology
|
October 20, 2023
Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide
Shruti U Gandhy, Fatima H Karzai, Marijo Bilusic, et al.
Plos One
|
November 11, 2022
Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinoma
Esther Mena, Joanna Shih, Joon-Yong Chung, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 2018
A Prospective Comparison of <sup>18</sup>F-Sodium Fluoride PET/CT and PSMA-Targeted <sup>18</sup>F-DCFBC PET/CT in Metastatic Prostate Cancer
Stephanie A Harmon, Ethan Bergvall, Esther Mena, et al.
Page
of 12